A detailed history of State Street Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,530,464 shares of AMPH stock, worth $58.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,530,464
Previous 1,529,536 0.06%
Holding current value
$58.6 Million
Previous $61.2 Million 21.4%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.99 - $50.09 $34,326 - $46,483
928 Added 0.06%
1,530,464 $74.3 Million
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $590,842 - $664,678
15,287 Added 1.01%
1,529,536 $61.2 Million
Q1 2024

May 15, 2024

BUY
$42.85 - $63.45 $1.85 Million - $2.74 Million
43,112 Added 2.93%
1,514,249 $66.5 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $518,130 - $732,882
11,646 Added 0.8%
1,471,137 $91 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $2.96 Million - $4.22 Million
64,987 Added 4.66%
1,459,491 $67.1 Million
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $1.25 Million - $2.04 Million
35,009 Added 2.58%
1,394,504 $80.1 Million
Q1 2023

May 15, 2023

BUY
$27.99 - $37.92 $27,570 - $37,351
985 Added 0.07%
1,359,495 $51 Million
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $4.9 Million - $5.48 Million
-175,283 Reduced 11.43%
1,358,510 $38.1 Million
Q3 2022

Nov 15, 2022

SELL
$27.56 - $37.75 $194,380 - $266,250
-7,053 Reduced 0.46%
1,533,793 $43.1 Million
Q2 2022

Aug 15, 2022

BUY
$29.79 - $42.29 $6.52 Million - $9.26 Million
218,895 Added 16.56%
1,540,846 $53.6 Million
Q1 2022

May 16, 2022

SELL
$22.96 - $36.45 $2.69 Million - $4.27 Million
-117,256 Reduced 8.15%
1,321,951 $47.5 Million
Q4 2021

Feb 14, 2022

SELL
$18.14 - $23.29 $383,261 - $492,071
-21,128 Reduced 1.45%
1,439,207 $33.5 Million
Q3 2021

Nov 15, 2021

BUY
$17.83 - $21.49 $363,803 - $438,481
20,404 Added 1.42%
1,460,335 $27.8 Million
Q2 2021

Aug 16, 2021

BUY
$17.11 - $20.92 $598,473 - $731,739
34,978 Added 2.49%
1,439,931 $29 Million
Q1 2021

May 17, 2021

BUY
$17.21 - $20.65 $2.1 Million - $2.51 Million
121,789 Added 9.49%
1,404,953 $25.7 Million
Q4 2020

Feb 16, 2021

SELL
$17.76 - $21.24 $130,109 - $155,604
-7,326 Reduced 0.57%
1,283,164 $25.8 Million
Q3 2020

Nov 10, 2020

BUY
$17.99 - $22.22 $544,593 - $672,643
30,272 Added 2.4%
1,290,490 $24.2 Million
Q2 2020

Aug 14, 2020

BUY
$14.25 - $22.46 $896,681 - $1.41 Million
62,925 Added 5.26%
1,260,218 $28.3 Million
Q1 2020

May 11, 2020

BUY
$12.66 - $20.08 $15.2 Million - $24 Million
1,197,293 New
1,197,293 $17.8 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.88B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.